Deloitte Officine Innovazione announces the launch of Cardiotech Accelerator initiating the phase of identification of startups and scaleups that respond to the innovation requests of the major players active in the cardiometabolic and chronic disease management sector. The selected startups will start working together with project partners and Deloitte Officine Innovazione. The aim will be to develop innovative pilot projects to introduce new solutions to the market or to enhance the core business.
The Cardiotech Accelerator project kicks off
The Cardiotech Accelerator project develops in three phases. The first, Call4Startup, provides for the closure of applications on November 30, 2021. To apply, please refer to the official site. Subsequently, the phase of Selection. The applications will also be selected on the basis of the skills of the partner companies of the project who will personally follow the selection. The third stage is l‘Acceleration and will start in February 2022. This phase will last 15 weeks and will aim to develop pilot projects that will be presented during the Demo Day.
The company comment
Francesco Iervolino, Partner of Deloitte Officine Innovazione and LS&HC Innovation Leader, states: “The number of patients suffering from cardiovascular disease is constantly increasing, causing more than 17 million deaths worldwide every year. Considering the incidence and risks associated with these pathologies, it is evident how much it is necessary to invest and make the most of the opportunities that technological innovation offers: remote monitoring solutions, intelligent devices and virtual care systems to intervene on patients with targeted actions, timely and personalized ”